Pharma company wins duty dispute on loan license basis, tribunal sets aside duty demand The tribunal ruled in favor of the appellant pharmaceutical company in a dispute over duty liability on final products manufactured under a loan license ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Pharma company wins duty dispute on loan license basis, tribunal sets aside duty demand
The tribunal ruled in favor of the appellant pharmaceutical company in a dispute over duty liability on final products manufactured under a loan license basis. The duty was held to be based on the cost of production by the loan licensee, as established in previous tribunal judgments in the appellant's favor. The tribunal set aside the duty demand against the appellant, maintaining consistency with its prior decisions and allowing the appeals.
Issues: 1. Duty liability on final products based on sale price vs. cost of production. 2. Applicability of previous tribunal judgments. 3. Pending Supreme Court decision on similar matter.
Analysis: 1. The case involves a dispute regarding duty liability on final products manufactured under a loan license basis. The appellant, a pharmaceutical company, entered into an agreement with another company for manufacturing medicaments. The Revenue claimed duty should be based on the appellant's sale price, while the appellant argued it should be based on the cost of production by the loan licensee. The adjudicating authority confirmed a duty demand against the appellant but dropped proceedings against the loan licensee. The appellant challenged this decision.
2. The appellant's counsel cited previous tribunal judgments in their favor, where similar issues were decided in their favor. The counsel argued that the issue had already been settled in their favor in previous cases involving different job workers and loan licensees. On the other hand, the Departmental Representative referred to a previous tribunal judgment and highlighted a difference of opinion, indicating that the matter was pending before the Supreme Court. The DR suggested keeping the matter pending until the Supreme Court's decision.
3. Upon considering the submissions, the tribunal found the facts undisputed that the medicaments were manufactured under a loan license from the other company, and the duty liability was based on the cost of production by the loan licensee. Referring to previous tribunal judgments in the appellant's own case, the tribunal noted that the issue had already been decided in favor of the appellant. The tribunal upheld the appellant's argument and set aside the impugned order, allowing the appeals. The tribunal decided not to deviate from its previous views and ruled in favor of the appellant based on the established precedent.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.